An Evaluation to Determine the Strongest CD4 Count Covariates during HIV Disease Progression in Women in South Africa

ConclusionOnly a few of the many previously suggested continuous CD4+ count clinical covariates showed the potential to become an important integral part of the treatment process. Prolonging the pre-treatment period of the HIV disease progression by effectively incorporating and managing the covariates for long-term influence on the CD4+ cell response has the potential to delay challenges associated with ART side effects.

Source: Infectious Diseases and Therapy - February 12, 2019 Category: Infectious Diseases Source Type: research